Patents
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
07/2011
07/21/2011CA2787121A1 New anti-malarial agents
07/21/2011CA2786957A1 Amidoacridine derivatives useful as selective inhibitors of ubiquitin specific protease 7
07/21/2011CA2785499A1 Isoindolinone inhibitors of phosphatidylinositol 3-kinase
07/21/2011CA2784769A1 Novel substituted triazole derivatives as gamma secretase modulators
07/21/2011CA2784007A1 Pyrrolidine derivatives
07/20/2011EP2345650A1 Amorphous (R)-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]-1H-benzimidazole as anti-ulcer agent
07/20/2011EP2345649A1 Benzimidazole compound in crystal form and salt thereof
07/20/2011EP2345643A1 New tertiary 8-hydroxyquinoline-7-carboxamide derivatives and uses thereof
07/20/2011EP2345642A1 Secondary 8-hydroxyquinoline-7-carboxamide derivatives for use as antifungal agents
07/20/2011EP2345641A1 New secondary 8-hydroxyquinoline-7-carboxamide derivatives
07/20/2011EP2345328A1 Composition for agricultural use
07/20/2011EP2344498A1 Process for the preparation of 1- ( 3-hydroxymethylpyrid-2 -yl ) -2 -phenyl-4-methylpiperazine and mirtazapine
07/20/2011EP2344479A2 1,2-benzisothiazolinone and isoindolinone derivatives
07/20/2011EP2344477A1 Small molecule bradykinin b2 receptor modulators
07/20/2011EP2344476A2 Tricyclic carbamate jak inhibitors
07/20/2011EP2344475A1 Quinazolinone, quinolone and related analogs as sirtuin modulators
07/20/2011EP2344474A1 Picolinamide derivatives as kinase inhibitors
07/20/2011EP2344473A1 Heterocyclic pim-kinase inhibitors
07/20/2011EP2344472A1 Isoquinolinone derivatives
07/20/2011EP2344471A1 7-piperidinoalkyl-3,4-dihydroquinolone derivative
07/20/2011EP2344470A1 3-azabicyclo[3.1.0]hexyl derivatives as modulators of metabotropic glutamate receptors
07/20/2011EP2344459A1 2,3-substituted indazole or 4,5,6,7-tetrahydro-indazoles as fxr modulators against dyslipidemia and related diseases
07/20/2011EP2344458A1 Heteroaryls amide derivatives and their use as glucokinase activators
07/20/2011EP2344457A1 Substituted spiroamines
07/20/2011EP2344456A1 Novel potassium channel blocker
07/20/2011EP2344453A2 Activators of human pyruvate kinase
07/20/2011EP2344157A1 Novel inhibitors
07/20/2011EP2252587B1 Piperidine sulfonamide derivatives
07/20/2011EP2185540B1 Pyrrolidine aryl-ether as nk3 receptor antagonists
07/20/2011EP2091927B1 Thiazole and oxazole-substituted arylamides
07/20/2011EP1697312B1 Hydroxamic acid esters and pharmaceutical use thereof
07/20/2011EP1605936B1 Aryl spirohydantoin cgrp receptor antagonists
07/20/2011EP1481966B1 Novel arylamidine derivative or salt thereof
07/20/2011EP1230237B2 Magnesium omeprazole
07/20/2011CN1972924B Novel compounds
07/20/2011CN102131801A 1, 2 disubstituted heterocyclic compounds
07/20/2011CN102131800A 5- and 6-membered heterocyclic compounds
07/20/2011CN102131799A Method for splitting omeprazole salts
07/20/2011CN102131798A Di-substituted phenyl compounds used as inhibitors of phosphodiesterase 10
07/20/2011CN102131797A Triazole derivatives and their use as nicotinic acetylcholine receptor modulators
07/20/2011CN102131783A Quinoline derivatives as axl kinase inhibitors
07/20/2011CN102131778A Heterocyclic gpcr agonists
07/20/2011CN102131501A Antitumor properties of no modified protease inhibitors
07/20/2011CN102127080A Method for producing chiral 8-(3-amino-piperidin-1-yl)-xanthines
07/20/2011CN102127058A Pyrimidine derivatives for the treatment of abnormal cell growth
07/20/2011CN102127057A Dipeptidyl peptidase inhibitors
07/20/2011CN102127056A Tubulin inhibitors
07/20/2011CN102127055A Single-photon and two-photon homocysteine fluorescent probes and use thereof
07/20/2011CN102127054A 3-(substituted dihydroisoindol-2-yl)-2,6-piperidinedione polymorph and pharmaceutical composite
07/20/2011CN102127053A Dipeptidyl peptidase inhibitors
07/20/2011CN102127023A 7-membered ring compound, process for producing the same, and use thereof
07/20/2011CN102126963A Spirobifluorene amido compound and preparation method thereof
07/20/2011CN101691355B Substituted 4-quinolinone compounds and preparation method thereof
07/20/2011CN101580489B Nitrogenous heterocyclic ring compound and preparation method and application thereof
07/20/2011CN101481353B Tetrahydro indazolone or tetrahydro indolone substituted indazole derivative and salt thereof
07/20/2011CN101454286B Method for producing phenoxypyridine derivative
07/20/2011CN101417910B Green nitration method of prazoles intermediate
07/20/2011CN101239971B Biphenyl derivatives
07/20/2011CN101239970B Biphenyl derivatives
07/20/2011CN101239969B Biphenyl derivatives
07/20/2011CN101239968B Biphenyl derivatives
07/19/2011USRE42562 EP4 receptor agonist, compositions and methods thereof
07/19/2011US7982043 Protein tyrosine kinase enzyme inhibitors
07/19/2011US7982037 (5-Methyl-2H-pyrazol-3-yl)-(2-phenylsulfanyl-quinazolin-4-yl)-amine; Anticancer agents; antidiabetic agents; Alzheimer's disease; inhibitors of Aurora-2 and GSK-3
07/19/2011US7981900 2-phenyl pyrimidines which are tubulin inhibitors
07/19/2011US7981894 Polymorphic forms of 1-′4-(5-cyanoindol-3-yl) butyl-4-(2-carbamoylbenzofuran-5-yl)piperazine hydrochloride
07/19/2011US7981889 e.g. 4-[5-(Piperidine-1-carbonyl)-furan-2-ylmethyl]-2H-phthalazin-1-one; enzyme poly(ADP-ribose)polymerase (synthase)-1 or poly ADP-ribosyltransferase (PARP-1) inhibitor; anticarcinogenic agent with BRCA2 deficient phenotype; septic shock; ischemic injury; hemorrhagic shock; multiple sclerosis
07/19/2011US7981882 e.g. 7-Chloro-3-(2,2,2-trifluoroacetyl)-6-trifluoromethanesulfonyloxy-2,3,4,5-tetrahydro-1H-benzo[d]azepine; antidepressant, anxiolytic agent; obesity, obsessive/compulsive disorder
07/19/2011US7981880 3-(aminomethyliden) 2-indolinone derivates and their use as cell proliferation inhibitors
07/19/2011CA2647346C Malate salts, and polymorphs of (3s,5s)-7-[3-amino-5-methyl-piperidinyl]-1-cyclopropyl-1,4-dihydro-8-methoxy-4-oxo-3-quinolinecarboxylic acid
07/19/2011CA2526663C Indole derivatives with apoptosis-inducing effect
07/19/2011CA2476186C Sulfonylamino-derivatives as novel inhibitors of histone deacetylase
07/19/2011CA2448561C Aminoquinoline derivatives and their use as adenosine a3 ligands
07/19/2011CA2432464C Excitatory amino acid receptor antagonists
07/19/2011CA2344169C Substituted 3-cyanoquinolines as protein tyrosine kinases inhibitors
07/14/2011WO2011085126A2 Methods and compositions of targeted drug development
07/14/2011WO2011084985A1 Cxcr3 receptor antagonists
07/14/2011WO2011084962A1 Analogs of dehydrophenylahistins
07/14/2011WO2011084922A1 Pro-drugs of (e) -7- (3- (2-amino-1-fluoroethylidene) piperidin-1-yl) -1-cyclopropyl-6-fluoro-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
07/14/2011WO2011083804A1 Indole derivative
07/14/2011WO2011083487A1 Sulfone compounds as 5-ht6 receptor ligands
07/14/2011WO2011083315A1 Compounds and their use
07/14/2011WO2011083304A1 Prodrugs of opioids and uses thereof
07/14/2011WO2011082566A1 A fluorescent dye, its preparation method and use thereof
07/14/2011WO2011082519A1 Geldanamycin derivatives, preparation methods and uses thereof
07/14/2011US20110173726 Pyrazole Compounds for Controlling Invertebrate Pests
07/14/2011US20110172432 Method for the synthesis of heterogeneous palladium catalysts, catalysts obtained and use of same
07/14/2011US20110172431 Process for producing 1-substituted trans-4-(substituted amino) piperidin-3-ol
07/14/2011US20110172427 Process for preparing certain cinnamide compounds
07/14/2011US20110172420 Sulfonamide derivatives of polycyclic dyes used for analytical applications
07/14/2011US20110172417 Heterogeneous Copper Nanocatalyst and Manufacturing Methods Thereof
07/14/2011US20110172416 Amidine derivative
07/14/2011US20110172415 Nitrogen-containing heterocycle derivatives substituted with cyclic group
07/14/2011US20110172276 Carboxamide compound and use of the same
07/14/2011US20110172275 Pyrrole compounds
07/14/2011US20110172274 Fluoro-substituted 3,4-diaryl-4,5-dihydro-1h-pyrazole-1-carboxamidine derivatives having cb1-antagonistic activity
07/14/2011US20110172270 2-'4(phenylamino)-piperidin-1-yl!-n-phenyl-acetamine derivatives and related compounds as neuropeptide y5 (npy5) ligands for the treatment of obesity
07/14/2011US20110172248 Substituted heteroarylamide analogs as mglur5 negative allosteric modulators and methods of making and using the same
07/14/2011US20110172247 Substituted heteroarylamine carboxamide analogs as mglur5 negative allosteric modulators and methods of making and using the same
07/14/2011US20110172244 Compounds and compositions as modulators of gpr119 activity